S196: ROPEGINTERFERON ALFA-2B ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES by H. Gisslinger, C. Klade, P. Georgiev, D. Krochmalczyk, L. Gercheva-Kyuchukova, M. Egyed, P. Dulicek, A. Illes, H. Pylypenko, L. Sivcheva, J. Mayer, V. Yablokova, V. Empson, K. Krejcy, H. Hasselbalch, R. Kralovics, J.-J. Kiladjian

Get full text